Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
The following presentations were recorded for the Multiple Myeloma Patient Education Symposium that was hosted by Dana-Farber Cancer Institute in 2021.
Q&A from Multiple Myeloma Patient Symposium: Ken Anderson, MD, and Paul Richardson, MDKen Anderson, MD, and Paul Richardson, MD, answer questions about multiple myeloma and its treatment.
A Patient's Perspective: James Bond and wife Kathy BondJames Bond shares his experience being diagnosed with, treated for, and living with multiple myeloma during Dana-Farber's Multiple Myeloma Patient Symposium.
Current and Future Treatment of Multiple Myeloma: Kenneth C. Anderson, MDKen Anderson, MD, discusses current and future treatment for multiple myeloma during Dana-Farber's 2020 Multiple Myeloma Patient Symposium.
Smoldering Multiple Myeloma: Irene Ghobrial, MDIrene Ghobrial, MD, presents on smoldering myeloma and current work aimed at preventing progression to multiple myeloma during Dana-Farber's 2020 Multiple Myeloma Patient Symposium.
Diagnosis, Prognosis and Risk In Multiple Myeloma: Nikhil C. Munshi, MDNikhil Munshi, MD, presents the diagnosis and risk assessment in multiple myeloma at Dana-Farber's 2020 Multiple Myeloma Patient Symposium.
New Directions in Treating Multiple Myeloma in the Era of Novel Agents: Paul G. Richardson, MDPaul Richardson, MD, discusses new directions and novel agents for treating multiple myeloma at Dana-Farber's 2020 Multiple Myeloma Patient Symposium.
Updates on Managing Bone Disease in Multiple Myeloma: Andrew Yee, MDAndrew Yee, MD, provides updates on managing bone disease for multiple myeloma patients during the 2020 Dana-Farber Multiple Myeloma Patient Symposium.
Cellular Immunotherapy for Multiple Myeloma: David Avigan, MDDavid Avigan, MD, discusses how cellular immunotherapy can be used in treating multiple myeloma during the 2020 Dana-Farber Multiple Myeloma Patient Symposium.
Symptom Management in Multiple Myeloma: Kim Noonan, DNP, ANP-BC, AOCNKim Noonan, DNP, ANP-BC, AOCN, discusses symptom management for multiple myeloma patients at Dana-Farber's 2020 Multiple Myeloma Patient Symposium.
New Patient Appointments
For adults: 877-442-3324For children: 888-733-4662
Learn more about Dana-Farber's Multiple Myeloma Program